Tyrosine kinase inhibition prevents deformation-stimulated vascular smooth muscle growth

Hypertension. 1994 Dec;24(6):706-13. doi: 10.1161/01.hyp.24.6.706.

Abstract

The goal of this study was to determine the role of tyrosine phosphorylation in transducing deformation-stimulated vascular smooth muscle growth. Rat aorta-derived vascular smooth muscle cells were cultured on flexible silicone elastomer membranes and subjected to cyclic deformation (15 cycles per minute, deformed 2 seconds, relaxed 2 seconds). Deformation significantly increased proto-oncogene expression, [3H]thymidine incorporation, [3H]leucine incorporation, and cell number. Time course studies showed an 8-hour lag between initiation of cell deformation and onset of [3H]thymidine incorporation, with peak levels achieved after 18 to 24 hours. Western analysis of protein blots from deformed cells (10 minutes) demonstrated increased levels of phosphotyrosine-containing proteins having molecular weights of 110 to 130 and 70 to 80 kD. Deformation-stimulated tyrosine phosphorylation was prevented by the tyrosine kinase inhibitor Herbimycin A. Tyrosine kinase inhibition also prevented deformation-stimulated vascular smooth muscle cell growth as measured by [3H]thymidine incorporation. Cyclic deformation stimulates vascular smooth muscle proliferation through activation of tyrosine kinases. Inhibition of tyrosine phosphorylation is an effective means of preventing deformation-induced vascular smooth muscle growth in vitro.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Differentiation
  • Cell Division
  • DNA / biosynthesis
  • Gene Expression
  • Male
  • Muscle, Smooth, Vascular / cytology*
  • Muscle, Smooth, Vascular / physiology
  • Physical Stimulation
  • Protein Biosynthesis
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Proto-Oncogenes
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction

Substances

  • DNA
  • Protein-Tyrosine Kinases